...
首页> 外文期刊>Stroke: A Journal of Cerebral Circulation >Acute hyperglycemia state is associated with lower tPA-induced recanalization rates in stroke patients.
【24h】

Acute hyperglycemia state is associated with lower tPA-induced recanalization rates in stroke patients.

机译:急性高血糖状态与中风患者中tPA引起的再通率降低有关。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND AND PURPOSE: Hyperglycemia (HG) has a deleterious effect in stroke patients by accelerating ischemic brain damage; moreover, its antifibrinolytic effect may also influence reperfusion. We aimed to study the effect of acute/chronic HG on tissue-type plasminogen activator (tPA)-induced recanalization. METHODS: We studied 139 consecutive stroke patients with documented intracranial artery occlusion treated with intravenous tissue-type plasminogen activator (tPA). Admission glucose levels were recorded (in mg/dL). The existence of previous chronic HG was determined by plasma levels of glycosylated hemoglobin (HbA1c, %) and fructosamine (in micromol/L). Transcranial Doppler monitoring assessed complete recanalization 2 hours after tPA bolus. National Institutes of Health Stroke Scale (NIHSS) scores were obtained at baseline and 48 hours. RESULTS: On admission, the median NIHSS score was 18 and mean glucose value was 140+/-63 mg/dL. At 2 hours, 32% of patients(n=44) achieved complete recanalization. Patients who recanalized showed lower admission glucose levels (127 vs 146 mg/dL; P=0.039) but no differences in HbA1c (6.3% vs 6.3%; P=0.896) or fructosamine (292 vs 293 micromol/L; P=0.957) were observed. Other variables associated with recanalization were initial distal middle cerebral artery occlusion (P=0.011) and platelet count (P=0.015). Patients with an admission glucose level >158 mg/dL had lower recanalization rates (16% vs 36.1%; P=0.035) and a higher NIHSS score at 48 hours (7 vs 14.5; P=0.04). After adjustment for stroke etiology, age, and risk factors, the only independent predictors on admission of no recanalization were glucose value >158 mg/dL (odds ratio [OR], 7.3; 95% confidence interval [CI], 1.3 to 42.3; P=0.027), proximal middle cerebral artery occlusion (OR, 2.6; 95% CI, 1.1 to 6.5; P=0.034), and platelet count <219,000/mL (OR, 2.6; 95% CI, 1.1 to 6.1; P=0.029). CONCLUSIONS: In tPA-treated patients, the acute but not chronic HG state may hamper the fibrinolytic process, delaying reperfusion of the ischemic penumbra. Early measures to reduce HG may favor early recanalization.
机译:背景与目的:高血糖(HG)通过加速缺血性脑损伤对中风患者具有有害作用。此外,其抗纤维蛋白溶解作用也可能影响再灌注。我们旨在研究急性/慢性HG对组织型纤溶酶原激活物(tPA)诱导的再通的影响。方法:我们研究了139例连续卒中患者,经静脉组织型纤溶酶原激活剂(tPA)治疗后颅内动脉闭塞。记录入院葡萄糖水平(mg / dL)。先前慢性HG的存在是由血浆糖基化血红蛋白(HbA1c,%)和果糖胺(以微摩尔/升计)的水平确定的。经tPA推注2小时后,经颅多普勒监测评估完全再通。美国国立卫生研究院卒中量表(NIHSS)评分是在基线和48小时获得的。结果:入院时中位NIHSS评分为18,平均血糖值为140 +/- 63 mg / dL。在2小时时,有32%的患者(n = 44)达到了完全再通。再次手术的患者的入院血糖水平较低(127 vs 146 mg / dL; P = 0.039),但HbA1c(6.3%vs 6.3%; P = 0.896)或果糖胺(292 vs 293 micromol / L; P = 0.957)无差异。被观察。与再通气相关的其他变量是最初的远端大脑中动脉闭塞(P = 0.011)和血小板计数(P = 0.015)。入院血糖水平> 158 mg / dL的患者在48小时时的再通率较低(16%vs 36.1%; P = 0.035)和NIHSS评分较高(7 vs 14.5; P = 0.04)。在对中风病因,年龄和危险因素进行调整后,唯一没有接受再通的独立预测因素是血糖值> 158 mg / dL(几率[OR]为7.3; 95%置信区间[CI]为1.3至42.3;其他人群为2)。 P = 0.027),近端大脑中动脉闭塞(OR,2.6; 95%CI,1.1至6.5; P = 0.034)和血小板计数<219,000 / mL(OR,2.6; 95%CI,1.1至6.1; P = 0.029)。结论:在tPA治疗的患者中,急性但非慢性HG状态可能会阻碍纤溶过程,从而延迟缺血半影的再灌注。早期减少HG的措施可能有利于早期再通。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号